Next report date
Report period
H1 2024
EPS estimate
1.31CHF
Revenue estimate
2.32 BCHF
1.684CHF
318.74 MCHF
4.88 BCHF
117.23 M
About UCB
Sector
CEO
Jean-Christophe Tellier
Headquarters
Brussels
Website
Employees (FY)
9.08 K
Founded
1925
FIGI
BBG006TLWZP8
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
UCB.BR short term bullish potential to challenge ATHConclusion:
A substantial break above 100, preferably above 107 signals a short term bullish potential, challenging ATH and beyond.
A drop below 75 on the other hand renders long term bearish or at least choppy consolidation.
For short term play targeting 108 minimally, with tight stop just under 96
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of UNC is 118.423 CHF — it has increased by 1.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange UCB stocks are traded under the ticker UNC.
UCB is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
UNC stock is 1.04% volatile and has beta coefficient of 1.02. Check out the list of the most volatile stocks — is UCB there?
UNC earnings for the last quarter are 2.57 CHF per share, whereas the estimation was 1.65 CHF resulting in a 55.93% surprise. The estimated earnings for the next quarter are 1.25 CHF per share. See more details about UCB earnings.
UCB revenue for the last quarter amounts to 2.53 B CHF despite the estimated figure of 2.48 B CHF. In the next quarter revenue is expected to reach 2.36 B CHF.
Yes, you can track UCB financials in yearly and quarterly reports right on TradingView.
UNC stock has risen by 1.05% compared to the previous week, the month change is a 6.37% rise, over the last year UCB has showed a 52.01% increase.
UNC net income for the last quarter is 29.74 M CHF, while the quarter before that showed 303.77 M CHF of net income which accounts for −90.21% change. Track more UCB financial stats to get the full picture.
Today UCB has the market capitalization of 23.15 B, it has increased by 1.54% over the last week.
Yes, UNC dividends are paid annually. The last dividend per share was 0.93 CHF. As of today, Dividend Yield (TTM)% is 0.75%. Tracking UCB dividends might help you take more informed decisions.
UCB dividend yield was 1.21% in 2023, and payout ratio reached 52.65%. The year before the numbers were 1.27% and 42.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, UNC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 9.08 K employees. See our rating of the largest employees — is UCB on this list?
We've gathered analysts' opinions on UCB future price: according to them, UNC price has a max estimate of 161.63 CHF and a min estimate of 102.86 CHF. Read a more detailed UCB forecast: see what analysts think of UCB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB EBITDA is 1.25 B CHF, and current EBITDA margin is 18.47%. See more stats in UCB financial statements.